Clinical Trials Directory

Trials / Unknown

UnknownNCT03906201

Effect of Phytoecdysterone Administration in Subjects With Prediabetes

Effect of Phytoecdysterone Administration on Cytotoxicity, Genotoxicity and Metabolic Control in Subjects With Prediabetes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
University of Guadalajara · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Prediabetes is the term used for people whose glucose levels do not meet the criteria for diabetes but are too high to be considered normal. This is defined by the presence of blood glucose between 100-125 mg / dL, values per glucose tolerance curve of 140-199mg / dL and/or HbA1c 5.7-6.4%. Prediabetes should not be considered as a clinical entity in itself, but as a risk factor for diabetes and cardiovascular disease (CVD). Prediabetes is associated with obesity (especially abdominal or visceral obesity), dyslipidemia with elevated triglycerides and/or low HDL cholesterol, and hypertension.

Detailed description

Subjects with a diagnosis of prediabetes are included according to the criteria of the American Diabetes Association in its version 2019, between 30 and 60 years old residents of the city of Guadalajara, Jalisco, Mexico who come to clinical nutrition consultation in the University Hospital Fray Antonio Alcalde from the city of Guadalajara, Jalisco, Mexico. The study design is a randomized, randomized clinical trial with a control group in two groups: an intervention group with ecdysterone 300mg every 24 hours for 12 weeks (approximately 90 days) and an approved placebo control group (magnesia stearate) ) at 300mg every 24 hours for 12 weeks (approximately 90 days).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEcdysteroneFood supplement of plant origin with pronounced biological activity and potentially hypoglycaemic
OTHERPlacebono pharmacologic effect

Timeline

Start date
2019-02-06
Primary completion
2020-07-31
Completion
2020-07-31
First posted
2019-04-08
Last updated
2019-10-31

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT03906201. Inclusion in this directory is not an endorsement.